
Biography
Jose A. Carrasco Lopez is the manager of the Earlham BIO Foundry. The BIO Foundry provides the UK bioscience community access to automated platforms for nano-scale modular DNA assembly, verification and delivery to plant and microbial cells. It is also able to serve as a repository for large collections of DNA parts.
Jose is a microbiologist and molecular biologist interested in pursuing biotech innovation and new approaches to solve human problems.
Jose obtained his PhD in Cellular and Molecular Biology studying the interaction of rhizosphere’s bacteria and legumes as a new tool for heavy metal bioremediation. In post-doctoral research at University of Maryland, Baltimore, USA, he first studied (at Patrik Bavoil lab) the role of the pmp gene family in Chlamydia trachomatis pathogenesis and, later on (at James Galen lab, CVD), developed attenuated Salmonella enterica serovars as live vector vaccine strains.
His experience includes more than 15 years working in the Microbiology, Molecular Biology and Biotechnology fields, studying host/pathogen interactions, human pathogens, developing vaccines and working with bacteria of industrial interest.
Publications
Related reading.

Finding fungi at the fen

The genetic machinery that drives biodiversity

On the origin of errors: the causes and consequences of mistakes during DNA replication

Could long-read RNA sequencing be the future of drug discovery?

Why is genome annotation important?

Why cloud computing is important for data-driven bioscience research

How bioinformatics can crack the complex case of protist biodiversity

The dramatic effects genomics will have on our future world

DNA Foundry propels Earlham Institute into precision genomics

Exotic wheat DNA could help breed ‘climate-proof’ crops

Sequencing project to unleash the huge potential of euglenoids

Circadian clock insights could be key to increased wheat yields

European consortium launched to reverse biodiversity loss through genomics research

Tracking bacterial evolution in real time spots emergence of antimicrobial resistance

Big Data initiative awarded £6.3 million as part of major UKRI investment in research infrastructure
